| Raymond Marshall Campbell, DNP, CRNA | |
|
600 Elizabeth St, Corpus Christi, TX 78404-2235 | |
| (361) 881-3000 | |
| Not Available |
| Full Name | Raymond Marshall Campbell |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 600 Elizabeth St, Corpus Christi, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063052025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | RN684189 (Pennsylvania) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 1089369 (Texas) | Primary |
| Entity Name | Emergenchealth Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467970897 PECOS PAC ID: 1355606641 Enrollment ID: O20180608000439 |
News Archive
The Taiwan AIDS Foundation in conjunction with the Rotary Club of Taipei North Star has launched an HIV prevention campaign that aims to educate people about HIV/AIDS in light of the upcoming Chinese Valentine's Day holiday, the China Post reports.
Imec have developed a prototype medical device based on silicon photonics for the screening of arterial stiffness and cardiovascular diseases.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, announced on December 13 the initiation of the regulatory process for a Glaucoma Phase II clinical study in Israel. Leading Medical Centers in Israel will enroll 44 patients with Ocular Hypertension or Glaucoma for the first segment of the trial, who will be treated for 16 weeks with CF101 or placebo.
In the United States, annual average levels of fine particulate matter-PM2.5, a measure of solid particles and liquid droplets that are 2.5 micrometers or smaller found in the air-declined 24% from 2009 to 2016, then increased 5% between 2016 to 2018.
Isotechnika Pharma Inc. today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use (CHMP) for formal review, which is expected to take one year.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raymond Marshall Campbell, DNP, CRNA 14041 Coquina Bay Ave, Corpus Christi, TX 78418-6546 Ph: (724) 968-8561 | Raymond Marshall Campbell, DNP, CRNA 600 Elizabeth St, Corpus Christi, TX 78404-2235 Ph: (361) 881-3000 |
News Archive
The Taiwan AIDS Foundation in conjunction with the Rotary Club of Taipei North Star has launched an HIV prevention campaign that aims to educate people about HIV/AIDS in light of the upcoming Chinese Valentine's Day holiday, the China Post reports.
Imec have developed a prototype medical device based on silicon photonics for the screening of arterial stiffness and cardiovascular diseases.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, announced on December 13 the initiation of the regulatory process for a Glaucoma Phase II clinical study in Israel. Leading Medical Centers in Israel will enroll 44 patients with Ocular Hypertension or Glaucoma for the first segment of the trial, who will be treated for 16 weeks with CF101 or placebo.
In the United States, annual average levels of fine particulate matter-PM2.5, a measure of solid particles and liquid droplets that are 2.5 micrometers or smaller found in the air-declined 24% from 2009 to 2016, then increased 5% between 2016 to 2018.
Isotechnika Pharma Inc. today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use (CHMP) for formal review, which is expected to take one year.
› Verified 2 days ago
Michael L Simmons, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2606 Hospital Blvd, Corpus Christi, TX 78405 Phone: 361-902-4000 Fax: 361-902-4949 | |
Mary Catherine Wegner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 5950 Saratoga Blvd, Christus Spohn South, Corpus Christi, TX 78411 Phone: 361-985-5700 | |
Ashley Riesberg, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 Elizabeth St, Corpus Christi, TX 78404 Phone: 361-881-3151 | |
Dr. Cody Lee Holliman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 Elizabeth St, Corpus Christi, TX 78404 Phone: 361-881-3000 | |
Maribel Seiler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6130 Parkway Dr, Corpus Christi, TX 78414 Phone: 361-883-6211 Fax: 361-882-4891 | |
Charlene Koehler, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2606 Hospital Blvd, Corpus Christi, TX 78405 Phone: 757-482-6732 | |
Steven M. Schoenicke, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 613 Elizabeth St, Suite 605, Corpus Christi, TX 78404 Phone: 361-883-1094 Fax: 361-882-4891 |